Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection

被引:36
作者
Karlas, JA
Siebelink, KHJ
van Peer, MA
Huisman, W
Cuisinier, AM
Rimmelzwaan, GF
Osterhaus, ADME
机构
[1] Erasmus Univ, Inst Virol, NL-3015 GE Rotterdam, Netherlands
[2] Virbac Labs, F-06511 Carros, France
关键词
D O I
10.1099/0022-1317-80-3-761
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cats were vaccinated with fixed autologous feline immunodeficiency virus (FIV)-infected cells in order to present viral proteins to the immune system of individual cats in an MHC-matched fashion. Upon vaccination, a humoral response against Gag was induced. Furthermore, virus-neutralizing antibodies were detected in a Crandell feline kidney cell-based neutralization assay, but not in a neutralization assay based on primary peripheral blood mononuclear cells. Despite the induction of these FIV-specific responses, vaccinated cats were not protected. Instead, accelerated virus replication was found, an observation similar to what previous experiments using other vaccine candidates have shown, Here, the results of the present study are discussed in the light of enhancement of lentivirus infections as a complicating factor in lentivirus vaccine development.
引用
收藏
页码:761 / 765
页数:5
相关论文
共 30 条
[1]   ENHANCEMENT OF SIV INFECTION WITH SOLUBLE RECEPTOR MOLECULES [J].
ALLAN, JS ;
STRAUSS, J ;
BUCK, DW .
SCIENCE, 1990, 247 (4946) :1084-1088
[2]   Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine [J].
Brichacek, B ;
Swindells, S ;
Janoff, EN ;
Pirruccello, S ;
Stevenson, M .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1191-1199
[3]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[4]   INVOLVEMENT OF GAG-SPECIFIC AND ENV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN PROTECTIVE IMMUNITY TO FELINE IMMUNODEFICIENCY VIRUS [J].
FLYNN, JN ;
BEATTY, JA ;
CANNON, CA ;
STEPHENS, EB ;
HOSIE, MJ ;
NEIL, JC ;
JARRETT, O .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (09) :1107-1113
[5]  
Flynn JN, 1996, J IMMUNOL, V157, P3658
[6]  
Goletti D, 1996, J IMMUNOL, V157, P1271
[7]   HIV-1 VIREMIA AND INFLUENZA [J].
HO, DD .
LANCET, 1992, 339 (8808) :1549-1549
[8]   Feline immunodeficiency virus vaccination: Characterization of the immune correlates of protection [J].
Hosie, MJ ;
Flynn, JN .
JOURNAL OF VIROLOGY, 1996, 70 (11) :7561-7568
[9]   ENHANCEMENT AFTER FELINE IMMUNODEFICIENCY VIRUS VACCINATION [J].
HOSIE, MJ ;
OSBORNE, R ;
REID, G ;
NEIL, JC ;
JARRETT, O .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 35 (1-2) :191-197
[10]   Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins [J].
Hulskotte, EGJ ;
Dings, MEM ;
Norley, SG ;
Osterhaus, ADME .
VACCINE, 1997, 15 (17-18) :1839-1845